Research Comparison
GHRP-6 vs Sermorelin
A side-by-side research comparison of GHRP-6 and Sermorelin drawn from Cobalt Peptides' peptide database records.
GHRP-6
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class. It stimulates endogenous growth hormone (GH) release via activation of the ghrelin receptor (GHS-R1a) in the hypothalamus and anterior pituitary. As one of the earliest developed GHRPs, GHRP-6 is well-characterised and widely used in research investigating GH pulsatility, appetite signalling, and metabolic regulation. It is known for its strong orexigenic (appetite-stimulating) effects in addition to GH release.
Sermorelin
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH 1–29), representing the shortest fully biologically active fragment. It functions as a physiologic stimulator of endogenous growth hormone (GH) secretion by acting on the anterior pituitary. Unlike exogenous GH administration, sermorelin preserves the natural pulsatile release of growth hormone, maintaining regulatory feedback mechanisms and reducing the risk of supraphysiological exposure. It is widely used in research contexts investigating growth hormone axis modulation, recovery, and metabolic regulation.